TrialJournal of medical genetics2017

Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.

Derralynn A Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.